Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3423851 | 0.84 | TSHR (0.42) | ALDH1A1TSHRCA12CA2CA9 | |
| SCHEMBL5066935 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRCA2CA9CHRNB2 | |
| SCHEMBL18832287 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL18868385 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRCA2CHRNB2CHRNB4 | |
| SCHEMBL1140820 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL17075233 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL26490218 | 0.76 | IDO1 (0.46) | ALDH1A1TSHRCA2 | |
| SCHEMBL3823942 | 0.75 | ALDH1A1 (0.46) | ALDH1A1TSHRCA2CA9CHRNB2 | |
| SCHEMBL13301452 | 0.75 | IDO1 (0.48) | — | |
| SCHEMBL17758157 | 0.75 | CYP3A4 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2233633-A | — | — | None | — | — | JP | disclosed |
| EP-3590977-B1 | SOLVENTLESS POLYMERIZABLE MIXTURE, METHOD FOR THE PREPARATION OF A FUNCTIONALISED POLYMER AND FUNCTIONALISED POLYMER | KARLSRUHER INST TECHNOLOGIE (DE) | 2020-09-30 | — | — | EP | disclosed |
| US-9751844-B2 | Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof | FUTURECHEM CO., LTD. (KR) | 2017-09-05 | — | — | US | disclosed |
| US-9751844-B2 | Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof | FUTURECHEM CO., LTD. (KR) | 2017-09-05 | — | — | US | disclosed |
| US-9751844-B2 | Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof | FUTURECHEM CO., LTD. (KR) | 2017-09-05 | — | — | US | disclosed |
| CN-103347909-B | In order to prepare precursor compound of being connected on the radiopharmaceutic solid carrier of 18F and preparation method and application | 未来化学株式会社 | 2016-08-10 | — | — | CN | disclosed |
| US-20140011961-A1 | PRECURSOR COMPOUND CONNECTED TO SOLID SUPPORT FOR MANUFACTURING 18F RADIOPHARMACEUTICAL, METHOD FOR MANUFACTURING SAME, AND APPLICATION THEREOF | FUTURECHEM CO., LTD. (KR) | 2014-01-09 | — | — | US | disclosed |
| US-20140011961-A1 | PRECURSOR COMPOUND CONNECTED TO SOLID SUPPORT FOR MANUFACTURING 18F RADIOPHARMACEUTICAL, METHOD FOR MANUFACTURING SAME, AND APPLICATION THEREOF | FUTURECHEM CO., LTD. (KR) | 2014-01-09 | — | — | US | disclosed |
| US-20140011961-A1 | PRECURSOR COMPOUND CONNECTED TO SOLID SUPPORT FOR MANUFACTURING 18F RADIOPHARMACEUTICAL, METHOD FOR MANUFACTURING SAME, AND APPLICATION THEREOF | FUTURECHEM CO., LTD. (KR) | 2014-01-09 | — | — | US | disclosed |
| CN-103347909-A | Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof | INDUSTRY UNIVERSTIY COOPERATION FOUNDATION SOGANG UNIVERSITY | 2013-10-09 | — | — | CN | disclosed |
| JP-H02233633-A | 4-ALLENYLOXYMETHYLSTYRENE AND PRODUCTION THEREOF | ARAKAWA CHEM IND CO LTD | 1990-09-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011961-A1 | PRECURSOR COMPOUND CONNECTED TO SOLID SUPPORT FOR MANUFACTURING 18F RADIOPHARMACEUTICAL, METHOD FOR MANUFACTURING SAME, AND APPLICATION THEREOF | PFAS, RFT1, AFF1 | ALDH1A1 1861/4885TSHR 351/4885CA12 802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.